Correction to: Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis
Clin Pharmacokinet
.
2022 Apr;61(4):591.
doi: 10.1007/s40262-022-01112-7.
Authors
Jessica Wojciechowski
1
,
Bimal K Malhotra
2
,
Xiaoxing Wang
3
,
Luke Fostvedt
4
,
Hernan Valdez
2
,
Timothy Nicholas
3
Affiliations
1
Department of Global Product Development, Pfizer Inc., Groton, CT, USA. Jessica.Wojciechowski@pfizer.com.
2
Department of Global Product Development, Pfizer Inc., New York, NY, USA.
3
Department of Global Product Development, Pfizer Inc., Groton, CT, USA.
4
Department of Global Product Development, Pfizer Inc., Cambridge, MA, USA.
PMID:
35178675
PMCID:
PMC8975786
DOI:
10.1007/s40262-022-01112-7
No abstract available
Publication types
Published Erratum